Du L - Search Results

1

Progress toward therapy with antisense-mediated splicing modulation.

Du L, Gatti RA. Du L, et al. Curr Opin Mol Ther. 2009 Apr;11(2):116-23. Curr Opin Mol Ther. 2009. PMID: 19330717 Free PMC article. Review.

2

Correction of prototypic ATM splicing mutations and aberrant ATM function with antisense morpholino oligonucleotides.

Du L, Pollard JM, Gatti RA. Du L, et al. Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):6007-12. doi: 10.1073/pnas.0608616104. Epub 2007 Mar 26. Proc Natl Acad Sci U S A. 2007. PMID: 17389389 Free PMC article.

3

Potential therapeutic applications of antisense morpholino oligonucleotides in modulation of splicing in primary immunodeficiency diseases.

Du L, Gatti RA. Du L, et al. J Immunol Methods. 2011 Feb 28;365(1-2):1-7. doi: 10.1016/j.jim.2010.12.001. Epub 2010 Dec 13. J Immunol Methods. 2011. PMID: 21147113 Free PMC article. Review.

4

Arginine-rich cell-penetrating peptide dramatically enhances AMO-mediated ATM aberrant splicing correction and enables delivery to brain and cerebellum.

Du L, Kayali R, Bertoni C, Fike F, Hu H, Iversen PL, Gatti RA. Du L, et al. Hum Mol Genet. 2011 Aug 15;20(16):3151-60. doi: 10.1093/hmg/ddr217. Epub 2011 May 16. Hum Mol Genet. 2011. PMID: 21576124 Free PMC article.

5

Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk.

Mitui M, Nahas SA, Du LT, Yang Z, Lai CH, Nakamura K, Arroyo S, Scott S, Purayidom A, Concannon P, Lavin M, Gatti RA. Mitui M, et al. Among authors: du lt. Hum Mutat. 2009 Jan;30(1):12-21. doi: 10.1002/humu.20805. Hum Mutat. 2009. PMID: 18634022 Free PMC article.

6

Functional significance of a deep intronic mutation in the ATM gene and evidence for an alternative exon 28a.

Coutinho G, Xie J, Du L, Brusco A, Krainer AR, Gatti RA. Coutinho G, et al. Among authors: du l. Hum Mutat. 2005 Feb;25(2):118-24. doi: 10.1002/humu.20170. Hum Mutat. 2005. PMID: 15643608

7

Nonaminoglycoside compounds induce readthrough of nonsense mutations.

Du L, Damoiseaux R, Nahas S, Gao K, Hu H, Pollard JM, Goldstine J, Jung ME, Henning SM, Bertoni C, Gatti RA. Du L, et al. J Exp Med. 2009 Sep 28;206(10):2285-97. doi: 10.1084/jem.20081940. Epub 2009 Sep 21. J Exp Med. 2009. PMID: 19770270 Free PMC article.

8

ATM is down-regulated by N-Myc-regulated microRNA-421.

Hu H, Du L, Nagabayashi G, Seeger RC, Gatti RA. Hu H, et al. Among authors: du l. Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1506-11. doi: 10.1073/pnas.0907763107. Epub 2010 Jan 4. Proc Natl Acad Sci U S A. 2010. PMID: 20080624 Free PMC article.

9

Functional characterization and targeted correction of ATM mutations identified in Japanese patients with ataxia-telangiectasia.

Nakamura K, Du L, Tunuguntla R, Fike F, Cavalieri S, Morio T, Mizutani S, Brusco A, Gatti RA. Nakamura K, et al. Among authors: du l. Hum Mutat. 2012 Jan;33(1):198-208. doi: 10.1002/humu.21632. Epub 2011 Nov 9. Hum Mutat. 2012. PMID: 22006793 Free PMC article.

10

A new series of small molecular weight compounds induce read through of all three types of nonsense mutations in the ATM gene.

Du L, Jung ME, Damoiseaux R, Completo G, Fike F, Ku JM, Nahas S, Piao C, Hu H, Gatti RA. Du L, et al. Mol Ther. 2013 Sep;21(9):1653-60. doi: 10.1038/mt.2013.150. Epub 2013 Jun 18. Mol Ther. 2013. PMID: 23774824 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,582 results

Search Page